Pharmacists in Henry, IL Accepting Medicare
1 Pharmacists found. Showing 1 - 1
 Thomas Victor Flores Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 808 University Ave, Henry, IL 61537 Phone: 309-364-4320 |
News Archive
Poor asthma training among GP's: Report
According to figures revealed by authorities, a lack of training for GPs in how to treat asthma is putting sufferers' lives at risk. Asthma UK says a survey found that 47 per cent of GPs admit their own knowledge about the condition could be better. Emergency hospital admissions for asthma cost the NHS over £60m a year, yet the charity maintains 75 per cent of admissions are avoidable. It estimates at least £45m could be saved if GPs were better informed and care was better managed.
DesignMedix receives $3 million NIH grant to develop new anti-malarial drug
DesignMedix, Inc., a biotech startup with ties to Portland State University, received a grant for almost $3 million from the National Institutes of Health to continue development and manufacture of a new anti-malarial drug.
Today's Op-Eds: ObamaCare and FEHBP; California prisons; and workhorse Medicaid
Even Washington's stupidest scandals can be revealing, and so it is with the liberal cri de snore that Republicans ought to renounce health insurance. Democrats have inadvertently drawn up another indictment of ObamaCare (12/4).
New genes that regulate longevity
In an effort to understand the molecular mechanisms that control aging, Howard Hughes Medical Institute researchers and their colleagues have now uncovered 10 new genes that regulate longevity in yeast. The studies also suggest a new model for how aging is slowed when caloric intake is restricted.
Preclinical data for potent IDO pathway inhibitor presented at AACR 2013 annual meeting
NewLink Genetics Corporation, a biopharmaceutical company primarily focused on discovering, developing and commercializing immunotherapeutic products in oncology, announced today that the company presented preclinical data for NLG919, a potent IDO (indoleamine-(2,3)-dioxygenase) pathway inhibitor, at the American Association for Cancer Research 2013 annual meeting.
› Verified 8 days ago